Last reviewed · How we verify

NCT03173079

Geriatric Assessment and Outcome in Patients Undergoing Transcatheter Aortic Valve Replacement

Completed Last updated 1 February 2021
What this trial tests

trial testing pre- and postinterventional geriatric assessment in patients undergoing TAVI in Influence of Geriatric Functional State on the Outcome After TAVI in 220 participants. Completed in 15 September 2020.

Timeline
15 March 2017
Primary endpoint
15 March 2019
15 September 2020

Quick facts

Lead sponsorCampus Bad Neustadt
StatusCompleted
Study typeOBSERVATIONAL
Enrollment220
Start date15 March 2017
Primary completion15 March 2019
Estimated completion15 September 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Campus Bad Neustadt

Who can join

70 and older, any sex, with Influence of Geriatric Functional State on the Outcome After TAVI or Possible Change in Geriatric Assessment After TAVI. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A geriatric assessment is becoming increasingly important in the treatment of patients with a percutaneous aortic valve replacement due to their comorbidities. The aim of this multimodal therapy concept is to examine the influence on the postoperative outcome. In addition to a comprehensive assessment of the individual frailty score, the subjective condition before and after TAVI is also evaluated using a standardized questionnaire ("Minnesota living with heart failure questionnaire").

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Campus Bad Neustadt trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03173079.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing